Your Health, We Care
selpercatinib, as a targeted drug targeting the RET gene, has shown significant efficacy in treating RET fusion positive metastatic non-small cell lung cancer and medullary thyroid carcinoma. However, as a medication, it may also cause some adverse reactions, and patients should pay close attention and follow the doctor's advice during use.
Selpercatinib is a targeted therapy drug that is specifically used for cancers a···【more】
Release date：2024-08-15Recommended：122
As a highly selective RET inhibitor, Selpercatinib can effectively block the RET···【more】
Release date：2024-08-15Recommended：156
Selpercatinib is a targeted drug for the treatment of RET gene mutations, which ···【more】
Release date：2024-08-14Recommended：135
